NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Diversified Holdings and Compass Group Diversified Holdings, LLC (NYSE: CODI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Compass you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/compass-diversified-holdings. Investors ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit. Investors have until July 14, 2 ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in UroGen you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/urogen-pharma-ltd-class-action-lawsuit. Investors have until July 28, 2025, to ask the Court ...

Darling Ingredients (DAR) shares rallied 9.2% in the last trading session to close at $36.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 6.6% loss over the past four weeks.Darling Ingredients stock is rising amid optimism surrounding recent developments, which suggest proposed rise in biofuel blending mandates. This policy shift may support stronger margins and improved performance across DAR’s core rene ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Civitas Resources, Inc. (NYSE: CIVI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Civitas you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/civitas-resources-inc. Investors have until July 1, 2025, to ask the Court to be appointe ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc. Investors have until July 11, 2025, to ask the Court to be appointed t ...

Investment Strategies - Warren Buffett's legacy emphasizes a buy-and-hold investment strategy, focusing on exceptional stocks and minimizing impulsive trading [1] Enterprise Products Partners (EPD) - EPD has a current stock price of $32.01 with a 12-month price forecast of $36.67, indicating a 14.54% upside potential [2] - Despite missing earnings expectations, EPD reported nearly 5% year-over-year revenue growth, showcasing resilience [3] - EPD offers a high dividend yield of 6.70% with a payout ratio of 80.15%, supported by a strong balance sheet and a history of increasing distributions [4] Intuitive Machines (LUNR) - Intuitive Machines has a current stock price of $10.45 and a 12-month price forecast of $16.06, representing a 53.64% upside potential [5] - The company is positioned to become a leading provider of lunar services as NASA plans future missions [6] - Analysts recommend a long-term view, with six out of nine analysts rating LUNR as a Buy, indicating an upside potential of over 47% [7][8] Alaska Air Group (ALK) - Alaska Air Group's current stock price is $47.40, with a 12-month price forecast of $66.83, suggesting a 41.00% upside potential [9] - The company is expanding through its Alaska Accelerate initiative and aims to generate $1 billion in incremental profit by 2027 [10] - Despite a 25% decline in shares over the past year, 11 out of 12 analysts view ALK as a Buy, indicating strong future potential [11] Service Corporation International (SCI) - Service Corporation International has a current stock price of $78.43 and a 12-month price forecast of $89.25, indicating a 13.80% upside potential [13] - The death services market is expected to grow significantly as the Baby Boomer generation ages, creating increased demand for services [14] - SCI is adapting to market changes with an insurance-funded pre-need sales model and has the infrastructure to meet rising demand [15]

I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up to Growth Stock Forum.Kiniksa Pharmaceuti cals (NASDAQ: KNSA ) is outperforming this year. The stock has advanc ...

While NVIDIA NASDAQ: NVDA remains the undisputed leader in AI GPU and infrastructure, its first-mover advantage doesn’t mean it's better. Advanced Micro Devices NASDAQ: AMD GPUs offer advantages to NVIDIA in many use cases due to their dollar-cost efficiency, user-friendliness, and superior compatibility with a wide range of 3rd-party products. The advantages run into performance. Advanced Micro Devices MI 355X has superior memory capacity and bandwidth to NVIDIA's Blackwell, making it an exceptional choice ...